OpenVSafe by OpenVAERS
Search V-safe

XUA-24737-08146

5 vaccinations 7 coded responses 40 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
56-60
ZIP prefix
940 / CA
Registered
2021-03-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-01
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-03
    Registered in v-safe
  4. 2021-03-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  5. 2021-03-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia, Lymphadenopathy, Pain in extremity — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  6. 2021-03-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Medical counselling — Feeling: Good · Site: Pain · Joint pains, Muscle or body aches · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  7. 2021-03-05
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  8. 2021-03-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Good · Site: Pain · Muscle or body aches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  9. 2021-03-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Good · Muscle or body aches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  10. 2021-03-08
    Survey response — 7 day, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  11. 2021-03-15
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-03-22
    Health check-in — 21 day, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-03-29
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-05
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-12
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-05-31
    Health check-in — 3 month, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-08-30
    Health check-in — 6 month, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-09-27
    Dose 3 — Pfizer-BioNTech
  19. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  20. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  23. 2021-10-04
    Health check-in — 7 day, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-10-11
    Health check-in — 14 day, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-10-18
    Health check-in — 21 day, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-10-25
    Health check-in — 28 day, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-11-01
    Health check-in — 35 day, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-11-08
    Health check-in — 42 day, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-12-27
    Health check-in — 3 month, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-02-15
  31. 2022-03-28
    Health check-in — 6 month, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-04-02
    Dose 4 — Pfizer-BioNTech
  33. 2022-04-14
    Survey response — 7 day, dose 4
    MedDRA: Oropharyngeal pain — Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  34. 2022-04-16
    Health check-in — 14 day, dose 4
    Feeling: Fair
    Adult check-in
  35. 2022-04-23
    Health check-in — 21 day, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-04-30
    Health check-in — 28 day, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-05-07
    Health check-in — 35 day, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-05-16
    Health check-in — 42 day, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-07-02
    Health check-in — 3 month, dose 4
    Feeling: Good
    Adult check-in
  40. 2022-09-22
    Dose 5 — Moderna
  41. 2022-10-01
    Health check-in — 6 month, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-10-09
    Health check-in — 14 day, dose 5
    Feeling: Good
    Adult check-in
  43. 2022-10-13
    Health check-in — 21 day, dose 5
    Feeling: Good
    Adult check-in
  44. 2022-10-20
    Health check-in — 28 day, dose 5
    Feeling: Good
    Adult check-in
  45. 2022-10-27
    Health check-in — 35 day, dose 5
    Feeling: Good
    Adult check-in
  46. 2022-11-03
    Health check-in — 42 day, dose 5
    Feeling: Good
    Adult check-in
  47. 2022-12-22
    Health check-in — 3 month, dose 5
    Feeling: Good
    Adult check-in
  48. 2023-03-23
    Health check-in — 6 month, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-07Pfizer-BioNTech
22021-03-01Pfizer-BioNTech
32021-09-27Pfizer-BioNTech No
42022-04-02Pfizer-BioNTech No
52022-09-22Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2021-03-05 Unsuccessful

Free text

Release 5

Systemic reaction (other): Swollen tender 3 centimeter axillary lymph node and two swollen tender 1 x 2 centimeter supraclavicular lymph nodes
Systemic reaction (other): Persistent progressive increased painful left axillary adenopathy,, now measuring 6x3 cm. Also increased left supraclavicular adenopathy. Increased pain in left shoulder and left upper extremity. I had also developed adenopathy after the first injection, though only about half the size. It persisted for the full three weeks until I had the second injection.
Systemic reaction (other): Persistent left axillary adenopathy, which increased in size to 6x5 cm last night with an 8/10 on the pain scale, but is now down to 5x4 cm and 5/10 pain. Persistent left supraclav nodes, now down to 1.5 cm
Healthcare visit (other): Phone consultation with infectious disease specialist
Systemic reaction (other): Left axillary adenopathy down to 3x3cm, still 5/10 tender. Left supraclav adenopathy two non tender1.5 cm nodes.
Systemic reaction (other): Persistent 3cm left axillary adenopathy, less tender, 4/10,, and persistent nontender left supraclav adenopathy
Systemic reaction (other): Persistent 3 cm left axillary adenopathy and two persistent 1 1/2 cm left supraclavicular nodes

Release 11

Systemic reaction (other): Sore throat

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
SROArthralgia ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROOropharyngeal pain · · ✓
SROPain in extremity ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…